{"groups":[{"description":"Participants with MM were observed retrospectively since the diagnosis up to death or lost to follow-up within the eligibility window of time (between January 1, 2008 and December 31, 2016), in this study.","id":"FG000","title":"Multiple Myeloma Participants"}],"periods":[{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"943"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"943"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}],"preAssignmentDetails":"Participants with a diagnosis of Multiple Myeloma (MM) were observed to collect data retrospectively between eligibility window: 1 January 2008 to 31 December 2016, in this study.","recruitmentDetails":"Participants took part in the study at 17 investigative sites in Brazil from 9 August 2018 to 27 January 2020."}